China Medical System (CHSYF) Stock Price, News & Analysis

Company Overview

China Medical System (OTCMKTS: CHSYF) is a China-based pharmaceutical company engaged in the research, development, manufacturing and marketing of branded generic drugs. The company focuses on therapeutic areas including cardiovascular and metabolic diseases, oncology, autoimmune disorders and central nervous system conditions. Its product portfolio comprises both patented and off‐patent medicines, with key offerings such as anti-hypertensives, antidiabetic agents, oncology treatments and neuroprotective formulations.

Founded in 1993 and headquartered in Guangzhou, China Medical System conducts its operations primarily within mainland China, leveraging an extensive sales and distribution network that reaches hospitals, clinics and specialty pharmacies across more than 30 provinces. Over the years, the company has established manufacturing facilities that meet international quality standards, supporting both in-house production and collaborative partnerships with global pharmaceutical firms.

R&D plays a central role in China Medical System’s strategy, with in‐house research teams dedicated to clinical development and regulatory approval. The company has invested in therapeutic pipeline projects targeting novel small molecules and biologics, often entering into licensing agreements or joint ventures to co‐develop new drug candidates. This approach has enabled China Medical System to supplement its generic drug offerings with innovative therapies under development or in late‐stage clinical trials.

China Medical System’s leadership team comprises industry veterans with extensive experience in pharmaceutical research, regulatory affairs and commercial operations. The board and executive management drive the company’s growth initiatives, emphasizing sustainable expansion in both established metropolitan markets and emerging regions. Through a combination of product diversification, strategic alliances and a robust distribution platform, China Medical System aims to strengthen its position as a leading provider of branded generics in China’s evolving healthcare landscape.

Key Stats

• Today's Range: $1.35 to $1.35
• 50-Day Range: $1.35 to $1.35
• 52-Week Range: $1.35 to $1.64
• Volume: N/A
• Average Volume: 4,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHSYF Stock Analysis - Frequently Asked Questions

How have CHSYF shares performed this year?

China Medical System's stock was trading at $0.9307 on January 1st, 2025. Since then, CHSYF stock has increased by 45.1% and is now trading at $1.35.

How do I buy shares of China Medical System?

Shares of CHSYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CHSYF
• CIK: N/A
• Web: www.cms.net.cn
• Phone: 852-2369-7678
• Fax: N/A
• Employees: 4,400
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A